Artificial Intelligence in Medicine Comprehensive Study by Type (Hardware, Software, Service), Application (Drug Discovery, Clinical Research Trial, Personalized Medicine, Others), Technology (Deep Learning, Querying Method, Natural Language Processing, Context Aware Processing) Players and Region - Global Market Outlook to 2028

Artificial Intelligence in Medicine Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Artificial Intelligence in Medicine Market Scope
Artificial intelligence (AI) is a field of computer science that can analyse large amounts of medical data. In many clinical settings, their ability to exploit significant relationships within a data collection may be employed in diagnosis, treatment, and prediction of result. Artificial intelligence in medicine can be defined as a scientific discipline concerned with research studies, projects, and applications aimed at assisting decision-based medical tasks through knowledge- and/or data-intensive computer-based solutions that ultimately support and improve a healthcare professional's performance. The lack of qualified healthcare workers and the development in the processing capacity of AI systems are two significant reasons driving the expansion of the AI in medicine market, which is expected to assist enhance the efficiency of drug discovery and clinical trial management.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledAlphabet Inc. (Google Inc.) (United States), Berg Health (United Kingdom), BioXcel Corporation (United States), Enlitic Inc. (United States), Intel Corporation (United States), General Vision (United States), IBM Corporation (United States), Microsoft Corporation (United States), Nvidia Corporation (United States) and Welltok Inc. (United States)
CAGR%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Artificial Intelligence in Medicine market throughout the predicted period.

Alphabet Inc. (Google Inc.) (United States), Berg Health (United Kingdom), BioXcel Corporation (United States), Enlitic Inc. (United States), Intel Corporation (United States), General Vision (United States), IBM Corporation (United States), Microsoft Corporation (United States), Nvidia Corporation (United States) and Welltok Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are InSilico Medicine, Inc. (Hong Kong), Flatiron Health (United States), GNS Healthcare (United States), Globavir Biosciences, Inc. (United States) and Benevolent AI (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Artificial Intelligence in Medicine market by Type , by Application (Drug Discovery, Clinical Research Trial, Personalized Medicine and Others) and Region with country level break-up.

On the basis of geography, the market of Artificial Intelligence in Medicine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In November 2020, BERG and AdventHealth partnered to reduce death rates for patients across hot zones across the United States. The partnership used AI to match patients with the best treatments based on their biological profiles. Their work in Florida has become a model for the rest of the country USA.



Influencing Trend:
Technical Progress in Medical Industry

Market Growth Drivers:
Digitization Across Different Industry Verticals and High Investment in Medical R&D

Challenges:
Fierce Competitive Pressure

Restraints:
Lack of Skilled Professionals and High Initial Investment

Opportunities:
Growth in Healthcare Infrastructure Across Emerging Regions

Key Target Audience
Artificial Intelligence Solution Providers, New Entrants and Investors, Venture Capitalists, Government Bodies, Corporate Entities, Government and Private Research Organizations and Others

Report Objectives / Segmentation Covered

By Type
  • Hardware
  • Software
  • Service
By Application
  • Drug Discovery
  • Clinical Research Trial
  • Personalized Medicine
  • Others
By Technology
  • Deep Learning
  • Querying Method
  • Natural Language Processing
  • Context Aware Processing

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Digitization Across Different Industry Verticals
      • 3.2.2. High Investment in Medical R&D
    • 3.3. Market Challenges
      • 3.3.1. Fierce Competitive Pressure
    • 3.4. Market Trends
      • 3.4.1. Technical Progress in Medical Industry
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Artificial Intelligence in Medicine, by Type, Application, Technology and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Artificial Intelligence in Medicine (Value)
      • 5.2.1. Global Artificial Intelligence in Medicine by: Type (Value)
        • 5.2.1.1. Hardware
        • 5.2.1.2. Software
        • 5.2.1.3. Service
      • 5.2.2. Global Artificial Intelligence in Medicine by: Application (Value)
        • 5.2.2.1. Drug Discovery
        • 5.2.2.2. Clinical Research Trial
        • 5.2.2.3. Personalized Medicine
        • 5.2.2.4. Others
      • 5.2.3. Global Artificial Intelligence in Medicine by: Technology (Value)
        • 5.2.3.1. Deep Learning
        • 5.2.3.2. Querying Method
        • 5.2.3.3. Natural Language Processing
        • 5.2.3.4. Context Aware Processing
      • 5.2.4. Global Artificial Intelligence in Medicine Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Artificial Intelligence in Medicine: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Alphabet Inc. (Google Inc.) (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Berg Health (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BioXcel Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Enlitic Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Intel Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. General Vision (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. IBM Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Microsoft Corporation (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Nvidia Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Welltok Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Artificial Intelligence in Medicine Sale, by Type, Application, Technology and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Artificial Intelligence in Medicine (Value)
      • 7.2.1. Global Artificial Intelligence in Medicine by: Type (Value)
        • 7.2.1.1. Hardware
        • 7.2.1.2. Software
        • 7.2.1.3. Service
      • 7.2.2. Global Artificial Intelligence in Medicine by: Application (Value)
        • 7.2.2.1. Drug Discovery
        • 7.2.2.2. Clinical Research Trial
        • 7.2.2.3. Personalized Medicine
        • 7.2.2.4. Others
      • 7.2.3. Global Artificial Intelligence in Medicine by: Technology (Value)
        • 7.2.3.1. Deep Learning
        • 7.2.3.2. Querying Method
        • 7.2.3.3. Natural Language Processing
        • 7.2.3.4. Context Aware Processing
      • 7.2.4. Global Artificial Intelligence in Medicine Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Artificial Intelligence in Medicine: by Type(USD Million)
  • Table 2. Artificial Intelligence in Medicine Hardware , by Region USD Million (2017-2022)
  • Table 3. Artificial Intelligence in Medicine Software , by Region USD Million (2017-2022)
  • Table 4. Artificial Intelligence in Medicine Service , by Region USD Million (2017-2022)
  • Table 5. Artificial Intelligence in Medicine: by Application(USD Million)
  • Table 6. Artificial Intelligence in Medicine Drug Discovery , by Region USD Million (2017-2022)
  • Table 7. Artificial Intelligence in Medicine Clinical Research Trial , by Region USD Million (2017-2022)
  • Table 8. Artificial Intelligence in Medicine Personalized Medicine , by Region USD Million (2017-2022)
  • Table 9. Artificial Intelligence in Medicine Others , by Region USD Million (2017-2022)
  • Table 10. Artificial Intelligence in Medicine: by Technology(USD Million)
  • Table 11. Artificial Intelligence in Medicine Deep Learning , by Region USD Million (2017-2022)
  • Table 12. Artificial Intelligence in Medicine Querying Method , by Region USD Million (2017-2022)
  • Table 13. Artificial Intelligence in Medicine Natural Language Processing , by Region USD Million (2017-2022)
  • Table 14. Artificial Intelligence in Medicine Context Aware Processing , by Region USD Million (2017-2022)
  • Table 15. South America Artificial Intelligence in Medicine, by Country USD Million (2017-2022)
  • Table 16. South America Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 17. South America Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 18. South America Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 19. Brazil Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 20. Brazil Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 21. Brazil Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 22. Argentina Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 23. Argentina Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 24. Argentina Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 25. Rest of South America Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 26. Rest of South America Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 27. Rest of South America Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 28. Asia Pacific Artificial Intelligence in Medicine, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 30. Asia Pacific Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 31. Asia Pacific Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 32. China Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 33. China Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 34. China Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 35. Japan Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 36. Japan Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 37. Japan Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 38. India Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 39. India Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 40. India Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 41. South Korea Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 42. South Korea Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 43. South Korea Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 44. Taiwan Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 45. Taiwan Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 46. Taiwan Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 47. Australia Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 48. Australia Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 49. Australia Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 50. Rest of Asia-Pacific Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 51. Rest of Asia-Pacific Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 52. Rest of Asia-Pacific Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 53. Europe Artificial Intelligence in Medicine, by Country USD Million (2017-2022)
  • Table 54. Europe Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 55. Europe Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 56. Europe Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 57. Germany Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 58. Germany Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 59. Germany Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 60. France Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 61. France Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 62. France Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 63. Italy Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 64. Italy Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 65. Italy Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 66. United Kingdom Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 67. United Kingdom Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 68. United Kingdom Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 69. Netherlands Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 70. Netherlands Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 71. Netherlands Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 72. Rest of Europe Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 73. Rest of Europe Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 74. Rest of Europe Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 75. MEA Artificial Intelligence in Medicine, by Country USD Million (2017-2022)
  • Table 76. MEA Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 77. MEA Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 78. MEA Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 79. Middle East Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 80. Middle East Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 81. Middle East Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 82. Africa Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 83. Africa Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 84. Africa Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 85. North America Artificial Intelligence in Medicine, by Country USD Million (2017-2022)
  • Table 86. North America Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 87. North America Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 88. North America Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 89. United States Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 90. United States Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 91. United States Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 92. Canada Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 93. Canada Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 94. Canada Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 95. Mexico Artificial Intelligence in Medicine, by Type USD Million (2017-2022)
  • Table 96. Mexico Artificial Intelligence in Medicine, by Application USD Million (2017-2022)
  • Table 97. Mexico Artificial Intelligence in Medicine, by Technology USD Million (2017-2022)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Artificial Intelligence in Medicine: by Type(USD Million)
  • Table 109. Artificial Intelligence in Medicine Hardware , by Region USD Million (2023-2028)
  • Table 110. Artificial Intelligence in Medicine Software , by Region USD Million (2023-2028)
  • Table 111. Artificial Intelligence in Medicine Service , by Region USD Million (2023-2028)
  • Table 112. Artificial Intelligence in Medicine: by Application(USD Million)
  • Table 113. Artificial Intelligence in Medicine Drug Discovery , by Region USD Million (2023-2028)
  • Table 114. Artificial Intelligence in Medicine Clinical Research Trial , by Region USD Million (2023-2028)
  • Table 115. Artificial Intelligence in Medicine Personalized Medicine , by Region USD Million (2023-2028)
  • Table 116. Artificial Intelligence in Medicine Others , by Region USD Million (2023-2028)
  • Table 117. Artificial Intelligence in Medicine: by Technology(USD Million)
  • Table 118. Artificial Intelligence in Medicine Deep Learning , by Region USD Million (2023-2028)
  • Table 119. Artificial Intelligence in Medicine Querying Method , by Region USD Million (2023-2028)
  • Table 120. Artificial Intelligence in Medicine Natural Language Processing , by Region USD Million (2023-2028)
  • Table 121. Artificial Intelligence in Medicine Context Aware Processing , by Region USD Million (2023-2028)
  • Table 122. South America Artificial Intelligence in Medicine, by Country USD Million (2023-2028)
  • Table 123. South America Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 124. South America Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 125. South America Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 126. Brazil Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 127. Brazil Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 128. Brazil Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 129. Argentina Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 130. Argentina Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 131. Argentina Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 132. Rest of South America Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 133. Rest of South America Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 134. Rest of South America Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 135. Asia Pacific Artificial Intelligence in Medicine, by Country USD Million (2023-2028)
  • Table 136. Asia Pacific Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 137. Asia Pacific Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 138. Asia Pacific Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 139. China Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 140. China Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 141. China Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 142. Japan Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 143. Japan Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 144. Japan Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 145. India Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 146. India Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 147. India Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 148. South Korea Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 149. South Korea Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 150. South Korea Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 151. Taiwan Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 152. Taiwan Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 153. Taiwan Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 154. Australia Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 155. Australia Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 156. Australia Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 157. Rest of Asia-Pacific Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 158. Rest of Asia-Pacific Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 159. Rest of Asia-Pacific Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 160. Europe Artificial Intelligence in Medicine, by Country USD Million (2023-2028)
  • Table 161. Europe Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 162. Europe Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 163. Europe Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 164. Germany Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 165. Germany Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 166. Germany Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 167. France Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 168. France Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 169. France Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 170. Italy Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 171. Italy Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 172. Italy Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 173. United Kingdom Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 174. United Kingdom Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 175. United Kingdom Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 176. Netherlands Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 177. Netherlands Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 178. Netherlands Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 179. Rest of Europe Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 180. Rest of Europe Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 181. Rest of Europe Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 182. MEA Artificial Intelligence in Medicine, by Country USD Million (2023-2028)
  • Table 183. MEA Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 184. MEA Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 185. MEA Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 186. Middle East Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 187. Middle East Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 188. Middle East Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 189. Africa Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 190. Africa Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 191. Africa Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 192. North America Artificial Intelligence in Medicine, by Country USD Million (2023-2028)
  • Table 193. North America Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 194. North America Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 195. North America Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 196. United States Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 197. United States Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 198. United States Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 199. Canada Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 200. Canada Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 201. Canada Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 202. Mexico Artificial Intelligence in Medicine, by Type USD Million (2023-2028)
  • Table 203. Mexico Artificial Intelligence in Medicine, by Application USD Million (2023-2028)
  • Table 204. Mexico Artificial Intelligence in Medicine, by Technology USD Million (2023-2028)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Artificial Intelligence in Medicine: by Type USD Million (2017-2022)
  • Figure 5. Global Artificial Intelligence in Medicine: by Application USD Million (2017-2022)
  • Figure 6. Global Artificial Intelligence in Medicine: by Technology USD Million (2017-2022)
  • Figure 7. South America Artificial Intelligence in Medicine Share (%), by Country
  • Figure 8. Asia Pacific Artificial Intelligence in Medicine Share (%), by Country
  • Figure 9. Europe Artificial Intelligence in Medicine Share (%), by Country
  • Figure 10. MEA Artificial Intelligence in Medicine Share (%), by Country
  • Figure 11. North America Artificial Intelligence in Medicine Share (%), by Country
  • Figure 12. Global Artificial Intelligence in Medicine share by Players 2022 (%)
  • Figure 13. Global Artificial Intelligence in Medicine share by Players (Top 3) 2022(%)
  • Figure 14. Global Artificial Intelligence in Medicine share by Players (Top 5) 2022(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Alphabet Inc. (Google Inc.) (United States) Revenue, Net Income and Gross profit
  • Figure 17. Alphabet Inc. (Google Inc.) (United States) Revenue: by Geography 2022
  • Figure 18. Berg Health (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 19. Berg Health (United Kingdom) Revenue: by Geography 2022
  • Figure 20. BioXcel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 21. BioXcel Corporation (United States) Revenue: by Geography 2022
  • Figure 22. Enlitic Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Enlitic Inc. (United States) Revenue: by Geography 2022
  • Figure 24. Intel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Intel Corporation (United States) Revenue: by Geography 2022
  • Figure 26. General Vision (United States) Revenue, Net Income and Gross profit
  • Figure 27. General Vision (United States) Revenue: by Geography 2022
  • Figure 28. IBM Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 29. IBM Corporation (United States) Revenue: by Geography 2022
  • Figure 30. Microsoft Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 31. Microsoft Corporation (United States) Revenue: by Geography 2022
  • Figure 32. Nvidia Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 33. Nvidia Corporation (United States) Revenue: by Geography 2022
  • Figure 34. Welltok Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. Welltok Inc. (United States) Revenue: by Geography 2022
  • Figure 36. Global Artificial Intelligence in Medicine: by Type USD Million (2023-2028)
  • Figure 37. Global Artificial Intelligence in Medicine: by Application USD Million (2023-2028)
  • Figure 38. Global Artificial Intelligence in Medicine: by Technology USD Million (2023-2028)
  • Figure 39. South America Artificial Intelligence in Medicine Share (%), by Country
  • Figure 40. Asia Pacific Artificial Intelligence in Medicine Share (%), by Country
  • Figure 41. Europe Artificial Intelligence in Medicine Share (%), by Country
  • Figure 42. MEA Artificial Intelligence in Medicine Share (%), by Country
  • Figure 43. North America Artificial Intelligence in Medicine Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Alphabet Inc. (Google Inc.) (United States)
  • Berg Health (United Kingdom)
  • BioXcel Corporation (United States)
  • Enlitic Inc. (United States)
  • Intel Corporation (United States)
  • General Vision (United States)
  • IBM Corporation (United States)
  • Microsoft Corporation (United States)
  • Nvidia Corporation (United States)
  • Welltok Inc. (United States)
Additional players considered in the study are as follows:
InSilico Medicine, Inc. (Hong Kong) , Flatiron Health (United States) , GNS Healthcare (United States) , Globavir Biosciences, Inc. (United States) , Benevolent AI (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 206 Pages 67 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Artificial Intelligence in Medicine Market are by type [Hardware, Software and Service], by end use application [Drug Discovery, Clinical Research Trial, Personalized Medicine and Others].
The Artificial Intelligence in Medicine Market is gaining popularity and expected to see strong valuation by 2028.
  • Digitization Across Different Industry Verticals
  • High Investment in Medical R&D

Know More About Global Artificial Intelligence in Medicine Report?